Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
73
days
First evidence of Tahyna virus in Central Italy and seasonal dynamics of its putative vector, Aedes caspius
Authors
Federico Romiti; Silvia Tofani; Antonella Cersini; Irene Del Lesto; Maria Teresa Scicluna; Gaetana Anita Marcario; Davide La Rocca; Silvia Rondón; Adele Magliano; Claudio De LiberatoShow moreShow less
Affiliations
Istituto Zooprofilattico Sperimentale del Lazio e della Toscana “M. Aleandri”, Rome, ItalyShow moreShow less
107
days
Type I interferon mitigates ZIKV-induced neuroinflammation and cell death in the central nervous system
Authors
Luciana Benevides; Herculano da Silva; Franciele Pioto; Thais da Silva Rigoni; Mariela Pires Cabral Piccin; Juliano de Paula Souza; Eurico Arruda; Vanessa Carregaro; João S. SilvaShow moreShow less
Affiliations
Fiocruz-Bi-Institutional Translational Medicine Plataform, Ribeirão Preto, São Paulo, Brazil; Department of Biochemistry and Immunology, Ribeirão Preto Medical School University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Department of Cell Biology and Virology Research Center, Ribeirão Preto Medical School University of São Paulo, Ribeirão Preto, São Paulo, BrazilShow moreShow less
160
days
Molecular epidemiological surveillance of the feline coronavirus reveals novel recombinant FCoV strains with evidence of ongoing viral evolution
Authors
Abid Ullah Shah; Csaba Varga; Nadine Moawad; Megan Rosen; Diane Levitan; Maged Gomaa HemidaShow moreShow less
Affiliations
Department of Veterinary Biomedical Sciences, Lewyt College of Veterinary Medicine, Long Island University, Brookville, NY, 11548, USA; College of Veterinary Medicine | Biomedical & Diagnostic Sciences, 2407 River Drive, Knoxville, TN, 37996, USA; Helping Promote Animal Welfare, Inc, NY, USAShow moreShow less
81
days
The murine correlate of the Epstein-Barr and Kaposi's sarcoma-associated γ-herpesviruses, MHV-68, represents a valuable model to assess antiviral drug sensitivity and combinatorial drug synergies
Authors
Christina Wangen; Debora Obergfäll; Katarína Briestenská; Jela Mistríková; William D. Rawlinson; Manfred MarschallShow moreShow less
Affiliations
Harald zur Hausen Institute of Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, Bratislava, 842 15, Slovakia; Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava, 845 05, Slovakia; Serology and Virology Division, NSW Health Pathology Microbiology, Prince of Wales Hospital, and Schools of Women's and Children's Health, Medicine and Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, AustraliaShow moreShow less
85
days
Deep learning-based structural prediction (AlphaFold 3) of shrimp IMNV RdRp and identification of seaweed-derived metabolites for antiviral intervention in aquaculture
Authors
Mostafizur Rahman; Md Ahad Ali; Tahosin Tasneem Samara; Monish Saha; Pritom Kundu; Hriddhi Sarker; Ankita Dutta; Neeraj KumarShow moreShow less
Affiliations
Department of Biotechnology and Genetic Engineering, Gopalganj Science and Technology University, Gopalganj, Bangladesh; Department of Computational Chemistry and Drug Design, Panacea Research Center, Bangladesh; Department of Chemistry, University of Rajshahi, Rajshahi 6205, Bangladesh; Department of Life Sciences, Independent University, Dhaka, Bangladesh; Department of Biochemistry and Cell Biology, Bangladesh University of Health Sciences, Dhaka, Bangladesh; Department of Pharmacy, University of Rajshahi, Rajshahi, Bangladesh; Department of Pharmacy, University of Science and Technology Chittagong, Chittagong, Bangladesh; Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Udaipur, Rajasthan, 313001, IndiaShow moreShow less
45
days
An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model
Authors
Jun Young Lee; Jung-ah Choi; Dae-Im Jung; Yunjeong Park; Eunji Yang; Chanmi Kim; Minkyung Ko; Seung Ho Baek; Jung Joo Hong; Soon-Hwan Kwon; Won-Tae Kim; Manki Song; Sang Hwan SeoShow moreShow less
Affiliations
KeyPrime Research, 193, Osongsaengmyeing 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28161, , Republic of Korea; Science Unit, International Vaccine Institute, Seoul, 08826, Republic of Korea; National Primate Research Centre, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Yeongudanji-ro, Ochang-eup, Chengwon-gu, Cheongju, Chungcheongbuk 28116, Republic of Korea; KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea; Department of Infectious Diseases, Armed Forces Medical Research Institute, Daejeon, Republic of KoreaShow moreShow less
FAQ
How long does VIRUS RESEARCH take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for VIRUS RESEARCH. The fastest paper went from submission to acceptance in 45 days (An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model, received 2026-07-06, accepted 2026-08-20); the slowest took 160 days. The average is 73.6 days and the median is 63 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
